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One of the main objectives of the WHO is controlling transmission of parasitic protozoa vector-
borne diseases. A quick and precise diagnosis is critical in selecting the optimal therapeutic regime 
that avoids unnecessary treatments and the emergence of resistance. Molecular assays based on 
loop-mediated isothermal amplification (LAMP) techniques are a good alternative to light 
microscopy and antigen-based rapid diagnostic tests in developing countries, since they allow for 
a large amount of genetic material generated from a few copies of DNA, and use primers that lead 
to high sensitivity and specificity, while the amplification process can be performed in isothermal 
conditions without the need of sophisticated equipment to interpret the results. In this review, the 
main advances in the development of LAMP assays for the diagnosis of malaria, leishmaniasis and 
Chagas' disease are discussed as well as the feasibility of their implementation in developing 
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Three main classes of parasites, organisms that live on or in a host organism getting its nutrients 
at the expense of its host, cause diseases in humans: i) protozoa, ii) helminths and iii) 
ectoparasites. Parasitic diseases remain a serious public health problem due to the high rates of 
global morbidity and mortality and the difficulty in their epidemiological control, especially in 
developing countries. It is estimated that more than 20% of the world´s population is infected with 
at least one parasite (Garrido-Cardenas, Mesa-Valle et al. 2018). Amongst all the parasitic 
diseases, malaria is the one responsible for the greatest number of deaths (500,000) each year 
and 216 million new cases, most of them affecting young children in sub-Saharan Africa. Malaria 
also contributes significantly to poverty; only in Africa, costs of illness, treatment, and premature 
death from malaria are estimated in at least $12 billion per year. (Moore, Wiffen et al. 2015) (Moore, 
Wiffen et al. 2015) (Moore, Wiffen et al. 2015) (Moore, Wiffen et al. 2015) (Moore, Wiffen et al. 
2015) (Moore, Wiffen et al. 2015) (Moore, Wiffen et al. 2015) (Moore, Wiffen et al. 2015)  
With the exception of malaria, most of the other main parasitic diseases are considered neglected 
tropical diseases (NTDs), affecting the poorest in developing countries and suffering from the lack 
of attention by the public health systems. NTDs affect one-sixth of the world’s population including 
parasitic diseases such as leishmaniasis, Chagas disease, human African trypanosomiasis, 
lymphatic filariasis, onchocerciasis and Guinea worm disease. Overall, NDTs lead to retardation of 
children growth, impairment of cognitive skills, lost ability to attend school or work and a serious 
economic burden placed on entire countries (Gandhi, Patil et al. 2016, CDC 2018)(Gandhi, Patil et 
al. 2016, CDC 2018)(Gandhi, Patil et al. 2016, CDC 2018)(Gandhi, Patil et al. 2016, CDC 
2018)(Gandhi, Patil et al. 2016, CDC 2018)(Gandhi, Patil et al. 2016, CDC 2018)(Gandhi, Patil et 
al. 2016, CDC 2018)(Gandhi, Patil et al. 2016, CDC 2018)(CDC 2018). 
Traditionally, the diagnosis of parasitic diseases has been carried out by microscopic examination 
of blood smears, tissue specimens, faeces, lymph node aspirates, bone marrow or cerebrospinal 
fluid looking for different parasitic stages. Preparation of the sample for optical microscopic analysis 
is tedious and time-consuming and requires trained personnel. However, this diagnostic method 
can be problematic in cases where the biological cycle of the parasite does not have any forms of 
elimination in humans or when patients have a low parasitic load or are asymptomatic (Schmitt, 
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Rosenblatt et al. 2012). For this reason, it is often necessary to use other diagnostic methods 
including serological assays and more recently, molecular-based assays. 
In developed countries, novel techniques are commercially available allowing a faster, highly 
specific and sensitive diagnosis for a wide range of parasites such as the Falcon assay screening 
ELISA test (FAST-ELISA), Dot-ELISA, rapid antigen detection system (RDTS), luciferase 
immunoprecipitation system (LIPS), loop-mediated isothermal amplification (LAMP), and diverse 
types of polymerase chain reaction (PCR) as nested PCR, multiplex PCR or Luminex (Ndao 2009). 
A comparison of all these techniques is illustrated in Table 1.  
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Table 1. Techniques commercially available for highly specific and sensitive diagnosis for a wide range of parasites. Adapted from: (Han 2013, WHO 
2018).  











(DNA or RNA) 
Specifity (identification of 
species) Possible Possible Possible Possible Possible Possible 
Quantification Yes Gold standard No No Yes Yes Yes 
Nucleic acids (NA) 
purification  Non required Non required Required Required  Required  Non required 
Temperature for NA 
amplification (°C) Non required Non required 40-98 40 98  60-65  
Time (h) 0.5-1 0.3 4 2 2 0.5–1 




Risk of contamination No No Low Low Low Potentially High 
Personnel Skill level High Low Medium/ High Medium Medium Medium/Low 
Equipment  Microscopy Not required Thermocycler Thermocycler  Thermocycler  Thermal block/ Water bath 
Cost Low Low/middle High High High Medium 
*In the case of Malaria, there are 200 different commercial kits. In 2007, FIND and WHO began implementation of a global RDT evaluation programme just recently completed.
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For a test to be uptaken by developing countries, the WHO indicated that a diagnostic test should 
be Affordable, Sensitive, Specific, User-friendly (simple to perform in a few steps with minimal 
training), Robust and rapid, Equipment free, and Deliverable to the end user (also known with the 
acronym ASSURED) (Mabey, Peeling et al. 2004). Based on these principles, several techniques 
have been developed in order to serve as point-of-care tests (POCT) aimed to be performed "in or 
near the patient care site". The best known are the rapid diagnostic test (RDT), which are lateral 
flow immuno-chromatographic tests. These systems are based on the use of a biological sample 
such as blood or urine in which a specific biomarker can be found (e.g. antigens, antibodies or 
oligonucleotides). These biomarkers can migrate by capillarity through a nitro-cellulose membrane 
on which specific bio-recognition and detection components are immobilized. However, RDTs have 
some limitations in terms of sensitivity and specificity due to cross-reactions with other parasites 
and similar proteins in the blood (Momcilovic, Cantacessi et al. 2018). Recently, nucleic acid (DNA) 
amplification tests (targeting pathogen biomarkers) have been developed with good sensitivity and 
specificity to be used with reduced infrastructure, and simple and fast handling. The best known of 
these techniques is LAMP (Njiru 2012) which will be described in more detail below.  
2. LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP): FROM ITS ORIGIN TO ITS 
APPLICATION AS POCT 
The loop-mediated isothermal amplification of DNA (LAMP) is a molecular technique that detects 
specific genes in the genome of a target parasite. This method is similar to conventional PCR in 
which DNA is also amplified. However, LAMP rapidly amplifies target DNA with high specificity and 
efficiency under isothermal conditions over a range of 60-65°C, using a strand displacement 
reaction(Notomi, Okayama et al. 2000).The auto-cycling strand displacement DNA synthesis is 
performed by a Bst (Bacillus stearothermophilus) DNA polymerase.This technique uses a DNA 
polymerase and a set designed primers (originally 4  - named F3 and FIP forward primers; B3c and 
BIP reverse primers) that recognize a total of six distinct sites on the target DNA (Notomi, Okayama 
et al. 2000, Nagamine, Hase et al. 2002).Subsequently, other two primers known as loop primers 
have been incorporated: loop primer forward [LPF] and loop primer backward [LPB] able to 




Fig 1. Schematic representation of designated DNA target sequences and primer design for 
LAMP.  Six distinct sites on the target DNA are recognized in the LAMP technique: two outer 
primers (F3 and B3), two inner primers, a forward inner primer (FIP) and a backward inner 
primer (BIP). FIP and BIP have two distinct sequences (known as hybrid primers) being one 
of them for priming the first step (F2 or B2 at the end 3’) and the other one for self-priming 
in later stages (F1C or B1c at the end 5’). LF and LB are known as loop primers and are able 
to accelerate the amplification reaction.  
One of the great advantages of LAMP is its high performance (sensitivity and specificity) due to the 
large amount of genetic material (up to 1010 copies) generated from a few copies of DNA and the 
binding of the multiple primers (Notomi, Okayama et al. 2000). The fact that the amplification takes 
place at a constant temperature allows the reaction to be performed in a simple thermoblock or 
water bath, not being required the use of more sophisticated equipments such as thermocyclers.In 
addition, the Bst polymerase is more tolerant than other PCR polymerases to the presence of 
inhibitors contained in the biological samples  which allows that the DNA template can be obtained 
by direct heat sample treatment not being required a previsous step for the DNA extraction. The 
LAMP mechanism is divided in two stages: a cyclic phase and a non-cyclic phase (Fig 2A-D & 3). 
The non-cyclic phase starts with the binding of the FIP primer by the interaction F2-F2c (primer-
DNA targeted sequence) at the 5 'end of the target DNA and the subsequent elongation. Next, the 
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first external F3 primer is joined to the sequence F3c which is located outside the junction of the 
FIP, displacing the previously formed one due to the chain shift activity of the Bst polymerase and 
releasing a very long strand with the first FIP at one end. Then, the complementary process takes 
place by joining the primer sequence B2 on the first BIP primer to the target DNA sequence B2c, 
subsequent elongation and interaction of the first B3 primer with the sequence B3c. When 
replicating again the DNA, a strand of small length is released that presents the FIP and BIP primers 
at each extreme which results in the generation of a loop structure.  
 
Fig. 2 First step of LAMP mechanism: the non-cyclic reaction and formation of dual looped 
DNA strand. Modified from (Bruce, Leterme et al. 2015). A) DNA synthesis initiated from FIP. 
B) F3 primer annealing and strand displacement DNA synthesis. C) DNA elongated from FIP 
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forms a loop structure at its 3’ end. D) DNA elongation from BIP and B3 primer in the same 
manner as (A-C). E) Stem-loop DNA as starting material for LAMP cycling (Animation 2018).  
The cyclic phase begins from the strand formed during the previous phase which presents a loop 
at each end (Fig 3). This phase has a rather complex mechanism in which only internal primers 
intervene. Using the DNA strand, the complementary strand is also formed with a loop at each end, 
and viceversa. During this process, a multitude of intermediate amplified DNA products of different 
sizes are formed to which the internal primers can also be joined and new amplifications can be 
started. When amplification is achieved, LAMP creates large amounts of DNA strands that contain 
multiple copies of the target DNA (Ushikubo 2004). During this reaction, magnesium pyrophosphate 
is generated as an insoluble white precipitate which becomes visible when the reaction is 
terminated. The increase of the magnesium pyrophosphate can be quantified by turbidity 
measurements (Mori, Nagamine et al. 2001). 
 
Fig. 3 Second and third step of LAMP: the cyclic amplification and elongation leading to 
strand displacement DNA synthesis. Modified from (Bruce, Leterme et al. 2015). 
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Later modifications of this technique focused in enabling visualisation of the reaction using the so-
called non-intercalating agents (like calcein (Tomita, Mori et al. 2008) and hydroxynaphtol blue 
(HNB) (Goto, Honda et al. 2009), which induce a colour change by chemical reaction. These agents 
do not inhibit the amplification process per se and can be incorporated from the beginning of the 
reaction avoiding the manipulation of the amplified products and decreasing the risk of 
contamination. Also, the detection of the amplified products can be performed using other 
intercalating agents such as SYBR® Green I that originates a colour change from orange (negative) 
to green (positive) (Zhang, Lowe et al. 2014). The main problem associated with the used of the 
latter component is that at certain concentrations can inhibit the amplification process and thus, it 
must be added at the end of the reaction increasing the risk of cross-contamination. Apart from for 
the reagents above mentioned, there are other more expensive agents that can be utilised, 
however, their use in developing countries is refractive (Zhang, Lowe et al. 2014). 
3. LAMP AS POCT(s) 
Originally, the LAMP technique did not strictly comply with all the ASSURED requirements in order 
to be applied as POCTs. However, various strategies have been developed with the aim to solve 
problems related to the maintenance of the cold chain, the avoidance of a previous DNA extraction, 
the development of new devices that facilitate its practical application in the field and the 




Fig. 4. Schematic workflow of a LAMP assay. In LAMP, denaturation of the double DNA helix 
is not required which makes simpler and shorter the process of the DNA extraction. 
However, the key factor for the success of the technique are the proper selection of the 
primers and the detection method as they will determine both the sensitivity and specificity 
of the assay.  
3.1. DNA extraction 
In the POCTs, there is a tendency to simplify and shorten all the steps, including the DNA extraction 
process. The classical extraction protocols of DNA such as phenol-chloroform, spin columns or 
magnetic beads, usually require some laboratory equipment and are time-consuming, so they have 
been replaced by other types of systems, the most frequently used, especially for blood samples 
such as rapid boiling methodology (Foley, Ranford-Cartwright et al. 1992), Chelex-100 resin 
(Wooden, Kyes et al. 1993), microwave irradiation method (Port, Nguetse et al. 2014) and more 
recently PURE DNA Extraction Kit, specially adapted for LAMP assay (FIND 2018). 
3.2. Reaction phase 
In order to avoid the need for cold transport and storage, the reaction mixture must be stabilized to 
avoid deterioration over time (Thekisoe, Bazie et al. 2009). Several methods have been used to 
stabilize the components of the LAMP reaction mixture such as drying (Hayashida, Kajino et al. 2015) 
and lyophilisation (Carter, Akrami et al. 2017) incorporating trehalose as a cryoprotectant. Another 
strategy consists on making modifications in the polymerases employed in the amplification in order 
to improve its stability. For example the Bst 2.0 Warm Start polymerase is a homolog designed in 
silico of the native Bst polymerase (Bst polymerase Large Fragment) but with a higher yield and 
reversibly linked to an aptamer that inhibits the enzyme up to 45ºC (Tanner, Zhang et al. 2012). 
This avoids that the amplification step occurs during the preparation of the reaction mixture at room 
temperature and the storage of the reactions without refrigeration for hours without altering the final 
result (Poole, Tanner et al. 2012). 
3.3. Detection Systems 
One of the advantages of LAMP lies in the possibility of visualizing the results with the naked eye 
or by simple techniques such as turbidimetry, since during the reaction, magnesium pyrophosphate 
is produced as a by-product in the form of an insoluble white precipitate which becomes visible, 
reducing the need for sophisticated equipment. The oldest studies basically used the visualization 
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of the precipitate of magnesium pyrophosphate (Poon, Wong et al. 2006, Han, Watanabe et al. 
2007). 
However, in order to increase the sensitivity, the visualization method has been modified, due to 
difficulties in the interpretation of the results and the visualization of amplified products. Some 
fluorescent, colorimetric or combined detection systems have been developed with the 
disadvantage of requiring expensive equipment for analysis (Fig. 5) (Parida, Sannarangaiah et al. 
2008).  
There are several reagents employed as detections systems (Table 2). Calcein is a chelating agent 
able to bind manganese ions present maintaining its fluorescence quenched. During amplification, 
the generated pyrophosphate ions will progressively depress the calcein molecules from 
manganese ions, resulting in an emission of green fluorescence when irradiated under natural, UV 
or blue light (Tomita, Mori et al. 2008). Other one is SYBR Green I, this molecule behaves as an 
intercalating agent that changes colour from orange to green upon interacting with DNA. It has the 
advantage that it can increase the sensitivity using UV light (Zhang, Lowe et al. 2014). Another 
reactive is SYTO-9 con la advantage of having a lower background noise and a better distinction 
from baseline fluorescence. This will lead to a reduction in misclassification of cases and non-cases 
by the users in the field (Patel, Oberstaller et al. 2013). 
Table 2. Most commonly employed detection systems in LAMP. 







Formed during the 
amplification process 
Calcein Fluorescence Orange (-) 
Green (+) 






+++ Added at the end of 





Colorimetric Violet (-) 
skyblue (+) 








Pre-added in the 
reaction mixture 
 
The chemical agents used in colorimetric assays are not intercalating agents but produce a change 
of colour based on a chemical reaction. These agents have the advantage of not inhibiting the 
amplification process and can be added from the beginning of the reaction, thus avoiding the 
subsequent manipulation of the amplified products and decreasing the risk of contamination, such 
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as HNB (Goto, Honda et al. 2009) or MG dyes (Lucchi, Ljolje et al. 2016).
 
Figure 5. Chemical structure of most commonly used fluorescent and colorimetric probes 
in LAMP assay. 
4. LAMP IN MALARIA DIAGNOSIS  
Malaria is caused by parasites of genus Plasmodium (P. falciparum, P. vivax, P. ovale, P. malariae 
and P. knowlesi) that are transmitted through the bites of infected female Anopheles mosquitoes. 
In 2016, there were estimated 216 million cases of malaria in 91 countries along with 445,000 
deaths (WHO 2018).  
Malaria infection produces fever and other non-specific symptoms such as rigors, headache, 
nausea and muscle aches. The most severe form of the disease is produced by P. falciparum and 
if the infection is not treated progresses to severe or complicated malaria, (severe anaemia, 
cerebral malaria, and respiratory distress) which may lead to death (Cowman, Healer et al. 2016). 
A rapid and correct diagnosis is essential, as well as an adequate treatment. Traditionally, the gold 
standard technique recommended to diagnose patients was the optical microscopy consisting on 
the observation of the parasite in blood by means of a smear or a thick drop and later staining the 
parasitic forms performed by highly qualified personnel. In the endemic areas, the WHO has 
indicated as priority the development of adequate diagnostic techniques to avoid the excessive 
prescription of antimalarial drugs, since in many cases clinical diagnosis of the disease was only 
made, without the appropriate and accurate laboratory diagnosis confirming the disease. 
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Immunochromatographic tests are rapid and accurate and very useful in the diagnosis of malaria. 
They are based on the capture of a parasite antigen from blood using monoclonal antibodies 
prepared against a malaria antigen target and conjugated to either a liposome containing selenium 
dye or gold particles in a mobile phase. Malaria antigens currently targeted are HRP-2 and pLDH 
(Moody 2002). Sensitivity will always depend on the concentration of the target antigen (protein) 
present in blood and will therefore vary with parasite density and may be reduced in areas where 
parasite densities are frequently < 200 parasites/μl (WHO 2018). 
There are numerous areas of low intensity of malaria transmission, where there are a large 
proportion of asymptomatic cases that are not detected microscopically. These asymptomatic 
individuals are a serious public health problem as they act as reservoirs for malaria transmission, 
making the elimination of the disease difficult. In non-endemic countries, the lack of experience of 
clinicians and laboratory technicians leads to delays and diagnostic errors, especially when the 
parasitaemia is very low and therefore can have fatal consequences. For this reason, in recent 
years, studies have been carried out in order to develop diagnostic tools for malaria with a greater 
sensitivity, specificity and cost-efficiently (Table 3). 
The first time LAMP was used in the diagnosis of malaria, was based on the detection of highly 
conserved 18S ribosomal RNA gene of P. falciparum without cross reaction with other human 
Plasmodium spp. Samples from Thailand, previously diagnosed by optical microscopy, were 
selected. The sensitivity and specificity of the LAMP technique was 95% and 99% respectively in 
relation to a conventional PCR, but with the additional advantage that the LAMP technique did not 
require prior DNA extraction, and visualization of the results it was performed through a real-time 
turbidimeter (Poon, Wong et al. 2006). 
Consecutively, Han et al (2007) developed an assay that allowed for differentiate between 
P.falciparum, P. vivax, P. malariae and P. ovale. The Plasmodium genus- and species-specific 
LAMP primer sets were designed on the basis of specific nucleotide sequences of the 18S rRNA 
genes of the 4 species. Positive samples were also analysed by optical microscopy. In this case, a 
pre-extraction process of the DNA with Chelex-100 was performed and the visualisation was 
carried out by turbidimetry. Apart from the high sensitivity and specificity similar to nested-PCR, the 
shorter processing time (half an hour) and the lower limit of detection (even when parasitaemia was 
very small (0,01% for P. falciparum) were additional advantages over the latter technique (Han, 




Most of the studies carried out so far have continued using as primers those that use the 18S rRNA 
as a target. They have been applied in studies carried out in different parts of the world, mainly to 
identify P. falciparum and P. vivax, although including modifications in the process of DNA 
extraction, use of thermoblock/bath, or the way of visualising the results. In any case, the aim was 
to simplify the process in order to apply the technique in remote areas with few infrastructures. 
Most of the countries where these studies have been conducted are endemic to P. falciparum 
and/or P. vivax malaria such as Thailand (Poschl, Waneesorn et al. 2010, Sattabongkot, Tsuboi et 
al. 2014), remote areas of central China with difficult access (Lu, Gao et al. 2012), in rural areas of 
Uganda (Hopkins, González et al. 2013), Bangladesh (Mohon, Elahi et al. 2014), Iran (Ghayour 
Najafabadi, Oormazdi et al. 2014), India (Patel, Lucchi et al. 2014, Singh, Singh et al. 2017), 
Zanzibar (Morris, Khamis et al. 2015) and Ethiopia (Cuadros, Perez-Tanoira et al. 2015). 
In countries where the disease is not endemic and there are no expert technicians available for its 
diagnosis, the 18S rRNA gene-based LAMP for diagnosis of imported malaria has also been used 
with a superior sensitivity to optical microscopy in Switzerland (Marti, Stalder et al. 2015) and 
Canada (Rypien, Chow et al. 2017). However, the sensibility of the 18S rRNA gene-based LAMP 
varies depending on the specie. For example, it can detect up to 50 parasite/μl of P. falciparum, P. 
vivax and P. ovale, but up to 500 parasites/μl of P. malariae. For this reason, different primers 
towards different targets have been developed to improve the sensitivity of the LAMP technique.  
Polley et al., 2010 developed an extensive work to select the most suitable primers. Eighteen 
genomic targets comprising both multiple- and single-copy loci were examined using First Explorer 
to find either species-specific or pan-genus first set. Mitochondrial gene-based (mtDNA) gave a 
positive result when tested with samples with very low parasite densities (5 parasites/μl) in much 
shorter time (< 30 min) compared to nested PCR protocols (Polley, Mori et al. 2010). The 
mitochondrial DNA (mtDNA) has been also chosen by other authors as the target region, because 
it is a plasmid-like multicopy non-nuclear DNA that it is easy to extract using the boiling method 
(Tao, Zhou et al. 2011). LAMP assays based on mtDNA has been employed in a wide range of 
countries for different purposes. In Colombia, this test has been used to differentiate P.falciparum 
from P.vivax (Vallejo, Martinez et al. 2015). In Ethiopia, mtDNA based-LAMP has been applied in 
the early detection of malaria in pregnant women leading to high sensibility (Tegegne, Getie et al. 
2017). In a larger study in Papua New Guinea, Malaysia, Ghana and Gambia, hydroxynaphthol 
blue was used as a colorimetric indicator in order to optimise the detection of malaria parasites 
(Britton, Cheng et al. 2015). Overall, using this technique, all the five human malaria species can 
be adequately differentiated with minimal instrumentation (Sattabongkot, Tsuboi et al. 2014, Lau, 
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Lai et al. 2016). Currently, the first kit in the market based on mtDNA is able to detect even up to 1 
parasite/µl of blood in less than 40 min (Gonzalze, Polley et al. 2011). This kit (Loopamp™ malaria 
Pan/Pf detection kits commercialised by Eiken Chemicals, Tokyo, Japan) employs primers form 
mtDNA consisting of plastic reaction tubes containing thermostable vacuum-dried reagents used 
to amplify Pan-Plasmodium/P. falciparum DNA which will be further described in more detail below. 
Other authors have selected mitochondrial cytochrome C oxidase subunit 1 gene which has also 
shown high sensibility and specificity in P.falciparum and P. vivax infections (Modak, Barber et al. 
2016). Other targets also used in LAMP assays are characterised by being conserved genes with 
several copies that are not in the genome of the host. The apicoplast is a plastid organelle, 
homologous to the chloroplasts in plants and found in some apicomplexan parasites like 
Plasmodium or Toxoplasma. It is semi-autonomous with its own genome and expression machinery 
and its genome copy number has been estimated to be approximately 15 for P. falciparum (Waller 
and McFadden 2005). The fact that presents a high number of copies makes the apicoplast a good 
candidate with high specificity and sensitivity able to detect low-density infections (2 parasites /μL) 
(Oriero, van Geertruyden et al. 2015, Oriero, Okebe et al. 2015).  
Although several trials have shown that P. falciparum can be differentiated from the rest of the 
genus species, due to the resurgence of P. vivax in various parts of the world, many authors have 
tried to design a LAMP assay able to detect P. vivax with the following characteristics: high 
sensitivity, specificity, fast and cost-efficient. In addition, it is important that the technique allows 
the detection of the parasite at the beginning of the infection or in case of relapses, and also when 
there are low parasitaemia since it has been shown that P. vivax can be easily transmitted in 
transfusions. 
At this respect, Patel et al. has used Pvr64 as target which is a highly conserved repeat family. 
They are six copies in the P. vivax genome. Five copies are on small contigs that are not assembled 
into chromosome scaffolds. As the Pvr64 family has a high degree of identity among the different 
species of Plasmodium, authors designed the primers (set r64) taking into account these similarities 
to avoid cross reactions. In order to validate the specificity of the first set r64, P. vivax strains from 
different geographic regions (Miami, El Salvador, Honduras, Mauritania, Indonesia, India, South 
Vietnam, North Korea, Thailand, New Guinea, Panama, Chesson, and Pakchong) were tested 
(Patel et al., 2013) The designed primers were able to detected P. vivax in the clinical samples with 
94.59% sensitivity and 100% specificity compared to the gold standard nested-PCR method (Patel, 
Oberstaller et al. 2013). 
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More recently, Britton et al. have designed an assay targeting the conserved cox1 gene which has 
demonstrated to possess excellent analytic sensitivity, being able to detect 1.4 parasites/μL 
(Britton, Cheng et al. 2016). The reason is due to the 11 copies/cell of cox 1 that are found in P. 
vivax, which greatly improves the sensitivity in relation to previous studies based on the 18S rRNA 
gene and even in others studies based on other chromosomes (r64 first set with a sensitivity around 
125 parasites/μL) (Patel, Oberstaller et al. 2013). 
Another target gene tested for the diagnostic of P. vivax is α-tubulin, which has a detection limit of 
100 copies/per reaction with a duration of 50 min. Validation of the α-tubulin LAMP assay showed 
the highest sensitivity when nested PCR was used as the gold standard (Dinzouna-Boutamba, 
Yang et al. 2014). LAMP assays have also targeted the identification of P. knowlesi, which is in 
many cases misdiagnosed by microscopy. Under microscopy, the early trophozoites are resembled 
morphologically those of P. falciparum, while the late and mature trophozoites, schizonts and 
gametocytes were generally indistinguishable from those of P. malariae making extremely difficult 
to identify P. knowlesi infections using only microscopy (Lee, Cox-Singh et al. 2009). Other LAMP 
assays were developed to exclusively identify P. knowlesi using other targets such as the apical 
membrane antigen-1 (AMA-1) gene found in all Plasmodium parasites during the late schizont 
stage. This protein plays a crucial role in the invasion of the host cell. LAMP has shown to be highly 
sensitive with the detection limit as low as ten copies for AMA-1 plasmid compared to nested PCR 
(100 copies) (Lau, Fong et al. 2011). However, Britton et al. showed that specificity was very low 
(53-55%) compared to microscopy and multiplex PCR when validating the gene COX1 as a target 
for P. vivax, due to the cross-reactivity between P. vivax and P. knowlesi COX1 (Britton, Cheng et 
al. 2016). 
In order to increase the sensibility of the technique, several researchers have used fluorescent 
probes such as SYBR Green I (Patel, Oberstaller et al. 2013, Oriero, van Geertruyden et al. 2015, 
Singh, Singh et al. 2017). 
The fact of adding SYBR Green at the end of the reaction implies the need to open the tubes and 
thus, the reaction mixture can be easily contaminated leading to erroneous results. Therefore, 
alternative systems have been sought to include the fluorochrome at the beginning of the reaction. 
In this sense, a range of incorporation systems of the fluorochrome has been developed. For 
example, microcrystalline wax-dye capsule containing the highly sensitive DNA fluorescence dye 
SYBR Green I have been prepared being incorporated at the beginning of the reaction leading to 
the release of the DNA dye to the reaction mixture only when the temperature is raised to the 
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melting point following amplification. Soon after cooling down, the solidified wax seals the reaction 
mix at the bottom of the tube, thereafter reducing the risk of aerosol contamination. This system 
allows for sensitivity and specificity of 98.3% and 100% respectively and quick visualised LAMP 
method, which is feasible for malaria diagnosis in resource-limited field settings (Tao, Zhou et al. 
2011). Nevertheless, Paris et al. showed that the UV fluorescence method produced a high rate of 
false positives and suggested that this method should be avoided as a LAMP read-out (Paris, 
Imwong et al. 2007). 
Several authors have used the pre-addition of hydroxynapthol blue (HNB) in the malaria LAMP 
reaction to improve the sensitivity of the technique making feasible to detect at least 5 parasites/μL 
in infected blood (Mohon, Elahi et al. 2014, Port, Nguetse et al. 2014, Britton, Cheng et al. 2015). 
Malachite green (MG)-LAMP assay has several advantages over other detection systems being 
very useful in epidemiology studies for malaria. The MG signal is highly sensitive and non-
subjective, facilitating the visual discrimination of results without any specialised and costly 
equipment such as turbidimeters or fluorescence readers. The colour change is visible for up 4 
weeks and the reagent can be added in the reaction mixture prior to amplification avoiding cross 
contamination and does not require a cold chain for storage (Lucchi, Ljolje et al. 2016). 
Yongkiettrakul et al., have developed a malaria LAMP-LFD system including the use of species-
specific biotinylated primers to amplify LAMP amplicons, which were hybridised to specific FITC-
labelled DNA probes and visualised on a chromatographic lateral flow dipstick. The duration of the 
assay was 1.5 h with similar sensitivity to conventional PCR when performed on plasmid DNA from 
malaria DHFR-TS genes, but 10 times higher when carried out on genomic DNA from P. falciparum 




Table 3. Summary of several LAMP modifications applied in the diagnosis of malaria.   
NAME MODIFICATIONS ADVANTAGES REFERENCE 
RealAmp LAMP-Tube 
scanner Contains an analyser  
During LAMP, specific amplification products can be formed but also 
some non-specific products. To avoid this phenomenon, a combined the 
LAMP method with a melting curve analysis using an analyser has been 
employed 
(Yamamura, 
Makimura et al. 
2009) 
 
 ESE-Quant Tube Scanner 
(Commercial manufacturer  
by ESE Gmbh, Stockach, 
Germany) 
Simple portable device (tube scanner) in which both the 
amplification platform (heating block) and fluorescent detection 
unit for end point use are incorporated 
The tube scanner is extremely sensitive, robust, and cost-effective and is 
easily portable 
(Lucchi, Demas et al. 
2010) 
Chromatographic lateral 
flow dipstick (LFD, Milenia® 
GenLine HybriDetect) 
LAMP-amplicons are hybridised to specific FITC-labeled DNA 
probes and visualised on a chromatographic lateral flow dipstick 
(LFD) 
Greater sensitivity (up to 0.001 ng of genomic DNA) 
(Yongkiettrakul, 
Jaroenram et al. 
2014) 
NINA-LAMP Non-instrumented nucleic acid amplification (NINA) coupled with LAMP system Electricity-free nucleic acid amplification 




Disposable microfluidic disc, which incorporates integrated sample 
preparation steps of DNA extraction, purification, elution and 
amplification 
Low cost, rapid and accurate amplification (Choi, Song et al. 2016) 
CZC-LAMP Direct blood dry LAMP 
DNA extraction is not necessary to detect low-density, even 
falciparum/non-falciparum mixed infection with a high degree of 
accuracy in blood samples 




The MinION™ nanopore sequencer is a pocket-sized and USB-
connected portable real-time sequencer.Amplicon sequencing of 
LAMP products using MinION™ allows to identify each 
Plasmodium species 
Rapid, simple, and highly sensitive system. 
Amplicon sequencing of LAMP products using MinION™ allows to 
identify each Plasmodium species. 
Identification of species and genotyping polymorphisms and resistant 
species   
(Imai, Tarumoto et al. 
2017) 
Multiplex microfluidic 
LAMP (mμLAMP) array 
system 
All analytical steps are integrated onto a chip including sample 
collection, nucleic acid preparation and molecular detection 
Visible with naked-eye, sensitive, specific and high-throughput 
diagnostic LAMP (Mao, Ge et al. 2018) 
3D printed microfluidic 
reactor array 
Fully 3D printed microfluidic reactor array that is capable of 
carrying out extraction, concentration and isothermal amplification 
of nucleic acids  
Miniaturised, inexpensive and multifunctional diagnostic device that can 
detect nucleic acids from complex biological samples 





5. COMMERCIALLY AVAILABLE LAMP KITS FOR MALARIA 
Currently there are two commercially available certified LAMP systems malaria from Eiken 
Chemical Co. and Meridina Bioscience Inc as described below.  
5.1.  Loopamp MALARIA kit (by Eiken Chemical Co.) 
The LoopampTM workflow allows for an easy DNA extraction and preparation of reaction mixtures 
in a just few steps without any additional equipment. It has been listed in the WHO Policy brief on 
malaria diagnostic in low-transmission settings. Reagent storage and shipment can take place at 
room temperature (as contains lyophilised reagents) and the test performance make possible that 
the molecular pathogen identification can be performed in rural areas. Differentiation between 
Plasmodium pan-species and Plasmodium falciparum is possible using this kit. It has high 
specificity (97 - 100%) and sensitivity (96 - 100%) with a detection limit of 1 parasite/μl and a 
duration of the process less than one hour. The interpretation of the results is easy and can be 
performed either visually or by means of a turbidimeter. 
5.2.  Illumigene Malaria LAMP (by Meridian Bioscience Inc., Cincinnati, OH). 
This kit consists of pre-dispensed, ambient temperature stable LAMP reagents designed to detect 
malaria parasites at the genus level. The LAMP assay is performed using the illumipro-10™ 
Incubator Reader. The change in turbidity associated with LAMP assays, due to the magnesium-
pyrophosphate build-up as a product, is measured by the illumipro-10 ™ reader and a qualitative 
result is determined. The kit uses a gravity filtration system to extract DNA instead centrifuge 
methods. It has a high sensitivity of 100% and a good specificity of 89.3%, the process duration is 
less than 50 minutes and the limit of detection ranged between 2.0 parasites/μl to 0.3 parasites/μl 
(Lucchi et al., 2016). 
6. LAMP ASSAYS FOR DIAGNOSIS OF LEISHMANIASIS 
Leishmaniasis is produced by more than 20 species of the parasitic protozoan Leishmania and is 
transmitted by infected female sandflies. According to the WHO, leishmaniasis is endemic in more 
than 98 countries and an estimated 350 million people are at risk. Clinical manifestations include 
from tegumentary leishmaniasis (TL) to the deadly visceral leishmaniasis (VL) (WHO 2018).The 
clinical evaluation of the signs and symptoms can guide the diagnosis, thus patients with VL will 
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frequently present fever, fatigue, loss of appetite and weight, and in more advanced stages of the 
disease, anaemia, enlargement of ganglia, splenomegaly and hepatomegaly. In addition, in the 
case of L. donovani, cutaneous lesions known as Post-kala-azar dermla leishmaniasis (PKDL) can 
appear after apparent healing, which has been mainly reported in India and Sudan (Zijlstra 2016).  
The term of tegumentary leishmaniasis (TL) refers to all forms of leishmaniasis that have skin 
manifestations. Depending on the Leishmania spp. and the immune system of the host, the clinical 
sign and symptoms can vary leading to Localized Cutaneous Leishmaniasis (LCL), Anergic Difusse 
Cutaneous Leishmanisis (ADCL) or Mucocutaneous or Mucosal Leishmaniasis (ML) (WHO 2018). 
LCL is the most frequent manifestation characterised by one or multiple ulcerated skin lesions. 
ADCL is characterised by a diffuse infiltration in the skin with nodules and papules that rarely form 
ulcers. In contrast, ML is characterised by a destructive mucosal inflammation. This diversity along 
with atypical lesions such as papules, verrucose vegetative lesions and skin infiltrations is related 
to the wide genetic variety in Leishmania spp. (Silveira, Lainson et al. 2004).The diversity in terms 
of clinical forms leads to inappropriate diagnose and hence, a delay in the instauration of the correct 
treatment and complications (Merino-Espinosa, Corpas-Lopez et al. 2018). 
Apart from the clinical manifestations, the diagnosis must be confirmed by other techniques, being 
the direct parasitological diagnosis as the gold standard due to its high specificity which is based 
on the demonstration of the presence of amastigote forms of the parasite by microscopic 
examination and staining of the tissues or the culture of the parasites from the samples of the 
patient. The main limitation is to obtain the samples, since it is necessary to use invasive 
techniques, like biopsies or scrapings from the lesion in the case of cutaneous forms and bone 
marrow or splenic aspirates in the VL (de Vries, Reedijk et al. 2015). 
In addition, the correct identification of the amastigotes in the stained imprints will depend on the 
quality of the reagents used as well as on the experience of the laboratory personnel. Therefore, it 
is common to culture the sample in a suitable medium such as NNN (Novy, Nicolle and McNeal). 
However, the technique is tedious, time-consuming and expensive (Srividya, Kulshrestha et al. 
2012). 
Immunological techniques, such as direct agglutination (DAT), indirect immunofluorescence 
(IFAT), ELISA or western-blot, are an alternative to direct diagnosis, although instrumentation is 
still required. The main disadvantage of immunological techniques is that they can cross-react with 
other parasitic diseases and autoimmune diseases, and also, antibody levels can remain elevated 
for a long time, making difficult to diagnose relapses. 
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For this reason, in recent years, rapid techniques based on the detection of antigens, such as latex 
agglutination (Sundar et al., 2006) and immunochromatographic assays based on the search for 
k39 antigen, have been developed with great success for VL (Maia et al., 2012). 
Alternatively, several PCR-based techniques have also been developed for the diagnosis of 
leishmaniasis (such as multiplex, nested, restriction fragment length polymorphism or quantitative 
real-time) based on the detection of various genes or genomic regions that offer different 
sensitivities and specificities. The main disadvantage of the use of this technique is that they require 
qualified personnel, expensive infrastructure and the time of experiment which limits its application 
as POCTs (Singh and Sundar 2015). 
Regarding LAMP assays, despite its numerous advantages compared to other DNA-based 
techniques, there are a limited number of studies regarding its use in the diagnosis of leishmaniasis. 
So far most studies aim to avoid if possible the use of invasive methods to obtain the sample. Even 
though, different primers have been developed in order to identify the genus Leishmania, no 
discrimination between different species has been achieved (Takagi, Itoh et al. 2009).  
Kinetoplastid parasites have a structure called kinetoplast that is constituted by mitochondrial DNA 
(kDNA) arranged in maxicircles and minicircles being of great interest in the design of specific 
primers. In several studies, primers based on the kDNA have been designed, specially oriented to 
the differential diagnosis of Leishmania spp. Takagi et al., 2009, applied a LAMP technique to 
detect Leishmania donovani DNA which was 10-fold more sensitive (up to 1 fg) than conventional 
PCR and did not interfered with other Leishmania species (L. infantum, L. major, L. mexicana, L. 
tropica, L. braziliensis) (Takagi, Itoh et al. 2009). 
The same primers were successfully applied using directly human blood. LAMP assay showed high 
sensitivity (being positive in 68 out of 75 of the confirmed VL infected patients) and high specificity 
(all controls were negative) being a better technique than PCR (Khan, Bhaskar et al. 2012). 
In a larger study with 200 samples from patients with VL infected L. donovani and post-kala-azar 
dermal leishmaniasis (PKDL), using the same primers as above mentioned. LAMP was positive in 
53 out of 55 blood samples (sensitivity 96.4%), 15 out of 15 bone marrow aspirate samples 
(sensitivity, 100%) and 60 out of 62 PKDL tissue biopsy samples (sensitivity, 96.8%). A LAMP 
modification incorporating the use of SYBR Green I for clear-cut naked eye detection was employed 
(Verma, Avishek et al. 2013). 
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In another study conducted in Iran, blood samples from 47 patients with clinical manifestations 
(hepatosplenomegaly, anaemia and fever) characteristic of VL and confirmed by an immunological 
diagnosis by the direct agglutination test (DAT) were analysed using LAMP. As control, 40 negative 
samples were used by DAT from non-endemic areas with no clinical signs or symptoms. A set of 
six targeting Leishmania infantum kDNA minicircle genes was designed for LAMP. The final 
detection was performed by observable turbidity with the naked eye. Even though, confirmation of 
the results was obtained by SYBR Green I and the colour change (green for the positive samples 
and orange for the negative samples). A more exhaustive confirmation was carried out by 
transferring the LAMP products for electrophoresis in agarose with ethidium bromide and 
visualizing under UV light. The detection limit was 1 parasite per 1 ml of blood, with a sensitivity of 
93.6% and a specificity of 100%, similar to those obtained with nested PCR used as a control. In 
addition, it was a specific test for detection of L. infantum, without interference of the rest of the 
species within the genus Leishmania (Ghasemian, Gharavi et al. 2014). 
One of the disadvantages of using the minicircles for primer design is that are highly variable, so 
they are not very suitable since this technique requires at least six conserved regions. The small 
subunit (SSU) 18S rRNA gene is one of the most used genes in phylogenetic studies, since they 
present a large number of copies. For this reason, several primers based on these genes have 
been developed in order to differentiate the different species. Adams et al have used a reverse 
transcriptase-loop-mediated isothermal amplification (RT-LAMP) assay in patients with VL from 
Sudan and with CL from Suriname to identify the Leishmania species responsible for the infection. 
The sensitivity of the RT-LAMP in the blood of the patients with VL was 83% in comparison with 
the analysis by microscopy of bone marrow and lymph node aspirates, whereas better results were 
obtained with CL, where the sensitivity was 98% (Adams, Schoone et al. 2010).  
Although the sensitivity of LAMP using 18S region is good, at least between 10 and 100 
parasites/ml are needed for detection. Additionally, the main drawback remains the false positives 
due to interferences with both Trypanosoma cruzi and T. brucei, due to the similarity of the 18S 
region among the kinetoplastids. Karani et al., 2014 developed a Pan-Leishmania LAMP assay 
using a sequence of L. major rRNA-encoding gene on chromosome 27 and designing two sets of 
primers to detect and differentiate L. donovani, L. major, L. infantum, L. braziliensis, L. guyanensis, 
L. tropica, L. mexicana, L. amazonensis, L. chagasi, L. siamensis, L. naiffi, L. lainsoni and L. 
panamensis. To develop the Pan-Leishmania LAMP assay, cultures of promastigotes of different 
Leishmania species were used. The so-called set 1 of primers led to better results in the detection 
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of the genus Leishmania with a limit of detection ranging from 30 pg to 36 fg of parasite DNA. In 
addition, no false positives were detected when analyzing other trypanosomatides such as T. brucei 
or T. evansi, or with other protozoa such as Cryptosporidium parvum, Giardia intestinalis or 
Entamoeba histolytica. However, this technique does not allow to differentiate between Leishmania 
species (Karani, Sotiriadou et al. 2014).  
Other authors have also designed a pan-Leishmania assay, using as target the 18S ribosomal RNA 
gene, preparing a consensus sequence from nine different Leishmania species. The study was 
carried out on both culture promastigotes and samples (blood, saliva or skin) from patients in 
Thailand. To improve the level of detection and facilitate the interpretation of results, malachite 
green was included, which is easily applicable in low-resource areas since it is cheap and can be 
stored at room temperature as previously discussed. This technique allowed to detect different 
species of Leishmania, such as L. martiniquensis and L. siamensis which are highly prevalent in 
this region. In addition, it was possible to detect Leishmania DNA both in the blood and bone 
marrow of patients with VL, and also in the skin and saliva in CL patients, respectively. Therefore, 
this assay could be applied as a noninvasive technique using saliva or blood, with levels of 
detection similar to those reported by Karani et al.(Sriworarat, Phumee et al. 2015). 
Overall, the LAMP technique allows to simplify and speed up the diagnostic process, however, the 
main problem is related to the DNA extraction process and in its conservation, especially in those 
environments where adequate infrastructures are not available to allow the correct preparation of 
the clinical sample and its storage requires refrigerated conditions. For this reason, several authors 
have combined the LAMP technique with FTA cards (Flinders Technology Associates) that protect 
the nucleic acids from oxidation, nucleases and UV damage at room temperature for long storage 
periods for the diagnosis of leishmaniasis. In this sense, Nzelu et al., 2016 have developed a one-
step, single-tube, highly sensitive LAMP assay for rapid detection of Leishmania DNA from tissue 
spotted on an FTA card, which has incorporated malachite green for the final visualisation step. 
The validation of this system was carried out on tissue samples obtained by aspirating or scraping 
the lesions of CL patients from Peru. The developed system was fast (30 min), sensitive (detection 
levels as low as 0.01 parasites/µl) and specific (without cross-reactivity with the genomic DNA of 
Trypanosoma cruzi, Trypanosoma brucei gambiense, human and dog) (Nzelu, Caceres et al. 
2016). 
Another of the genes traditionally used in the molecular identification of Leishmania is the ribosomal 
ITS1, since it is a highly conserved gen. A LAMP assay has recently been optimized including two 
primers designed based on shared regions of the ITS1 gene and a third primer from a newly 
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identified region in the Leishmania donovani genome. The three systems allow to detect 
concentrations of L. donovani DNA (> 100fg), being more sensitive than the conventional ITS1-
PCR (el Tai, Osman et al. 2000). To avoid contamination and false positives, the green nucleic acid 
stain SYTO16 was included in the initial reaction mixture at low concentrations making the test 
inexpensive, portable for real time monitoring and substantially more sensitive (> 100 fg of L. 
donovani DNA) than conventional ITS1-PCR or kDNA-PCR (Abbasi, Kirstein et al. 2016). 
Recently, Eiken Chemical Co. (Japan), in collaboration with FIND and other partners, has 
developed the Loopamp Leishmania Detection Kit for commercialization (Eiken 2018). Target 
genes, 18S rDNA and kDNA, were chosen based on multiple strands and conservation across 
multiple strains and species of Leishmania across geographic areas, with the aim of being able to 
diagnose both VL and CL. Bst DNA polymerase is used for amplification, and the dry reagents 
include a calibration to allow for the visual detection of the amplified products without opening the 
reaction tubes (Adams, Schoone et al. 2018).  
The selection of the target genes was performed using a bibliographic engine search and the 
analysis of the sequence alignment. Prototype primer sets were based on three target genes: i) the 
18S rDNA gene, ii) the histone H3 gene for pan-Leishmania assays and iii) kDNA for a VL-specific 
assay. The detection limit (LOD) was evaluated using a real-time LAMP turbidimeter. The 18S 
rDNA gene had a LOD ranging from 0.01 to 0.001 parasite /µl. The histone LAMP primers had a 
LOD similar to 18S rDNA but could not amplify all L. guyanensis and L. braziliensis. kDNA exhibited 
a LOD of 0.0001 parasite / µl on L. donovani and L. infantum but there was no amplification with 
CL-causing Leishmania species.  
The primers designed on 18S rDNA and kDNA genes were selected and combined to optimize the 
identification of VL using the dried-up LAMP assay developed by Eiken Chemical Co(Eiken 2018). 
The optimization of the assay was performed using samples of suspected CL patients from 
southwest Colombia (obtaining a sensitivity of 95% and a specificity of 86%). In the case of VL, 50 
blood samples from Ethiopian patients were used, and the technique showed a sensitivity of 92.3% 
and a specificity of 100% on whole blood (Adams, Schoone et al. 2018). 
Subsequently, several studies have evaluated the use of this kit using samples from different 
origins and on different species of Leishmania. Mukhtar et al., 2018 analysed blood samples from 
patients with VL in Sudan using two immunological techniques, the rK28 RDT and DAT. The rK28 
RDT presented higher sensitivity and specificity (98.81% and 100 % respectively) than DAT. The 
LAMP kit had high specificity regardless of the type of DNA extraction method used or sample 
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analysed, (whole blood or buffy coat), avoiding the need for invasive lymph node aspiration 
(Mukhtar, Ali et al. 2018). Ibarra-Meneses et al., 2018, demonstrated that by combining this kit with 
a portable and robust real-time fluorimetry, a versatile assay able to diagnose VL in situations in 
which the serological diagnosis is useless such as in VL relapses and test-of-cure, or VL / HIV co-
infection and even in canine leishmaniasis was possible (Ibarra-Meneses, Cruz et al. 2018). 
7. LAMP IN DIAGNOSIS OF AMERICAN TRYPANOSOMIASIS (T. CRUZI) 
American trypanosomiasis or Chagas disease is a parasitic infection caused by the protozoan 
Trypanosoma cruzi. It is a zoonosis transmitted by hematophagous insects of the family 
Reduviidae. There are alternative routes of transmission such as transfusion, mother-to-child, 
transplants of solid organs, consumption of food contaminated with the faeces of the insect vector, 
non-cooked meat of infected mammals or laboratory accidents. The exact number of infected 
people is unknown, although it is estimated that approximately 7-8 million people are infected 
worldwide (WHO 2018). 
The diagnosis of Chagas disease varies according to the stage of the disease. In the acute phase, 
there are numerous peripheral blood parasites and it is possible to detect them by direct peripheral 
blood fresh microscopy due to their rapid movements between blood cells. Smears of peripheral 
blood and thick blood, properly stained, allow the observation of the morphological characteristics 
of the parasite. When the level of parasitaemia is low, however, it is necessary to use concentration 
techniques, such as the Strout method or the buffy coat (WHO 2018). The diagnosis in the acute 
phase is of extreme importance due to the high efficacy of the treatment at this phase. Once the 
chronic phase is established (asymptomatic or symptomatic), the parasitaemia gradually 
decreases, making it difficult to perform the direct parasitological diagnosis in blood. Xenodiagnosis 
is a classic method, which has been used in the chronic phase where few parasites are found in 
the blood. Uninfected triatomine bugs from laboratory colonies are allowed to feed on the patient. 
Afterwards, the bugs are dissected about 20-25 days after feeding and the hind gut contents are 
examined under the microscope for the presence of T. cruzi epimastigotes. 
One of the great difficulties in the diagnosis of Chagas disease is that patients do not always have 
symptoms in the acute or chronic phase. Apart from that, in the chronic phase there is a high 
production of IgG-specific antibodies that are easily detectable by serological techniques. These 
antibodies, in most patients, will be present throughout life. 
Among the different immunological methods available, the most used are ELISA, IFAT and indirect 
haemagglutination (IHA). Currently, there is no gold standard with 100% sensitivity and specificity, 
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so the serological diagnosis of certainty is based on the concordance of, at least, using two 
techniques with different principles and antigens. In addition, we must take into account that in 
endemic areas it can cross-react with non-pathogenic Trypanosoma rangeli or with Leishmania spp 
(WHO 2010). This is of special importance in the screening of blood donors due to potential 
transmission of Chagas disease through blood transfusion (WHO 2007, S. 2010).  
Molecular PCR techniques have been considered as a promising alternative. However, the main 
problem arises in chronic patients where there is a low and sometimes intermittent parasitaemia or 
sometimes only a few parasites remain in some tissues. Different types of PCR have been used 
(nested, multiplex, PCR-hybridation), but their diagnostic value has been questioned since it is 
difficult to find a correlation with serological tests. Real-time PCR have been developed with greater 
sensitivity than previous methods. For the design of primers, the variable region of the minicircle 
kinetoplast DNA (kDNA), a repeat tandem sequence of nuclear DNA (stDNA), ribosomal RNA 
(rRNA) or the paraflagellar rod (PFR) genes have been used (Ramirez, Guhl et al. 2009, Schijman 
2018). 
It should be born in mind that seven genotypes have been described in T.cruzi that are called 
discrete typing units or DTUs (TcI-TcVI and Tcbat). These DTUs have substantial genetic diversity 
translated into differences in epidemiology and / or biological behaviour and should be taken into 
account when designing diagnostic techniques (Zingales 2018). 
 
Despite the sensitivity and specificity of molecular techniques, their use in the diagnosis of 
trypanosomiasis in endemic countries is limited due to the high price of equipment needed and the 
shortage of qualified personnel. This is why LAMP can be a promising technique in these countries. 
Thekisoe et al., in 2007 developed different primers sets from 18S rRNA genes for T. congolense 
and T. cruzi and 5.8S rRNA-internal transcribed spacer 2 (ITS2) gene for T. brucei gambiense and 
VSG RoTat1.2 gene for T. evansi (REF). These LAMP first sets were highly sensitive and capable 
of detecting up to 1 fg trypanosomal DNA, which is equivalent to ~0.01% genomic DNA (Thekisoe, 
Kuboki et al. 2007). Thekisoe et al. also developed new assays for T. cruzi and T. rangeli targeting 
the 18S ribosomal RNA (rRNA) and small nucleolar RNA (snoRNA) genes (Thekisoe, Kuboki et al. 
2007). This assay is able to differentiate between T. cruzi and T. rangeli, which is important 
considering that the latter is a non-pathogenic trypanosomatid that infects humans through the 
same vectors but leads to cross-reactions (Thekisoe, Rodriguez et al. 2010). 
Recently, a LAMP Trypanosoma cruzi prototype kit has been developed by Besuschio et al., in 
collaboration with Eiken Chemical Co., Ltd. (Japan), the company that had previously developed a 
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LAMP kit for malaria and Leishmania (Besuschio, Llano Murcia et al. 2017). The repetitive satellite 
DNA sequence of T. cruzi was used as molecular target. This kit has the advantage that it uses 
reagents in dry form on the inside of the cap of the reaction tubes. The detection system is 
consisting of calcein that allows the direct visualization of the reaction by either naked-eye or 
fluorescence. Calcein is included in the reaction tubes in a quenched state, bound to manganese 
ions. The Bst DNA polymerase used in the LAMP reaction is not affected by blood and tissue-
derived components such as myoglobin, heme-blood protein complexes and immunoglobulin G. In 
order to determine the sensitivity and specificity of the kit, purified DNA from different T. cruzi 
isolates was used. A validation of the kit was performed using a range of well-characterised blood 
samples from Chagas disease patients at different stages and with different clinical manifestations. 
Blood was included from seronegative donors as non-infected controls. Therefore, this prototype 
kit detects T.cruzi DNA at concentrations 1 x 10−2 fg/μL using purified DNA and 1x10−2 parasite 
equivalents/mL (“parasite equivalent” means the equivalent genomic content of one parasite cell) 
in extracts from spiked EDTA blood samples. The analytical sensitivity of this LAMP assay was 
superior to other studies using a LAMP procedure based on the 18S rDNA gene (Thekisoe, 
Rodriguez et al. 2010, Rivero, Bisio et al. 2017). 
8. FUTURE PERSPECTIVES AND CONCLUDING REMARKS 
The control of malaria and other neglected diseases transmitted by vectors requires the application 
of different types of strategies ranging from vector control, diagnosis, treatment of patients to search 
for vaccines. Due to the measurements applied in the Millennium Development Goals (MDGs), the 
number of malaria deaths has been reduced by half in 2016, the incidence of African 
trypanosomiasis has been reduced to less than 3000 new cases in the world in 2015 and the 
transmission of kala-azar in the Indian sub-continent has also been diminished drastically (WHO 
2018). However, we are still far from eradicating all these diseases, due to the emergence of 
parasite resistance to treatments, the resistance of vectors to insecticides and the maintenance of 
the parasite cycle due to reservoirs or asymptomatic individuals. 
Therefore it is necessary to maintain the control of the different routes that lead to expansion of 
propagation of the disease. In this sense, the proper diagnosis of infected patients, especially the 
asymptomatic ones, is fundamental. The LAMP technique is a useful tool for diagnosis, because 
of its ease of use especially in regions of scarce resources where neglected diseases are endemic. 
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There are numerous studies aimed at developing systems that are highly sensitive, specific, 
affordable, easy and quick to use. The involvement of academic institutions such as universities 
and research centers together with non-profit organizations, such as Foundation for Innovative New 
Diagnostics (FIND) in the search and identification of target genes, evaluation of new detection 
systems, the development of integrated teams, maintenance of clinical trials platforms, bank 
sample management, etc. have generated very promising results to date. However, in order to 
ensure that these systems reach the patient, the involvement of companies is also necessary. In 
this sense Eiken Chemical Co has been the first one in developing one commercial LAMP kit for 
malaria with an affordable price (FIND 2018). 
However, there are still a number of limitations in order to consider these systems as POCTs. 
Although integrated equipment are available able to undertake DNA extraction, amplification and 
detection, the size of the equipment is fundamental, so that it can be easily transported for use in 
remote areas. The Systems μ-Total Analysis System (μ-TAS) or "lab-on-a-chip" seem to be one of 
the most promising technologies (Notomi, Okayama et al. 2000, Choi, Song et al. 2016) in that 
respect along with the NINA-LAMP systems that do not require an electrical connection (Sema, 
Alemu et al. 2015). 
Another handicap is the identification of the species responsible for the infection. Although some 
LAMP systems have been developed able to identify the parasites at the gender level or 
differentiate some species from others (for example Pan/P. falciparum), it is often necessary either 
to know the specific species to apply the most appropriate treatment or to determine if they are 
strains resistant to the usual drugs. LAMP would also be very useful in epidemiological studies to 
know the parasitic species in insect transmitters in order to apply vector control measurements. To 
this end, some researchers have proposed the incorporation of a small MinION™ type sequencer 
into the LAMP assay (Imai, Tarumoto et al. 2017). 
Thinking of future emerging technologies, the next generation of molecular POCT devices should 
be able to connect to smart mobile phones being able to send the results to the clinician and the 
clinician to the patient in order to ensure a fast and suitable treatment. On the other hand, mobiles 
with global positioning would help in field epidemiological studies, providing information on the 
appearance and spread of new outbreaks and the effectiveness of control eradication programs 
(Song, Pandian et al. 2018). 
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